Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of SPK 0602 (pentamycin) vaginal tablets vs placebo in symptomatic vaginitis
2007-007659-15Phase 2Completed
- Sponsor
- Lumavita
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentamycin in bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis (trich) and 1 more (4 arms), sponsored by Lumavita. Primary endpoints: Efficacy in bacterial vaginosis, Efficacy in candidiasis and trichomoniasis and 1 more. Started Feb 2008; status: completed.
02
Drugs
pentamycin
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)trichomoniasis (trich)vaginitis
Beyond the preview
Go deeper on 2007-007659-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007659-15.